Medical Membrane Devices: Markets and Technologies

Published - Jul 2009| Analyst - Susan Hanft| Code - MST043D
Market Research Report Single User License: $2750 Member Price: FREE

Report Highlights

  • The medical membrane device market, which includes dialyzers, blood oxygenators, IV filters and blood/apheresis filters, is valued at nearly $2 billion in 2009 and is expected to increase at a compound annual growth rate (CAGR) of 4.6% through 2014
  • Sales of dialyzers and blood oxygenators and IV filters are primarily market-driven, while sales of blood/apheresis filters and diagnostic devices are principally technology-driven
  • Sales of diagnostic devices continue to skyrocket. Applauded by managed care, a growing number of point-of-care (POC) and home tests are available for a host of new and existing applications.

INTRODUCTION

STUDY GOAL AND OBJECTIVES
 
This BCC Research market opportunity study provides an in-depth analysis of the relevant technical and economic drivers for the medical membrane device market by technology type, forecasting growth and trends in the various sectors over the next 5 years. The conclusions are illustrated with important statistical and analytical information on markets, applications, industry structure and dynamics, as well as technological developments.
 
REASONS FOR DOING THIS STUDY
 
This report is intended for those who require a thorough analysis of the medical membrane device industry.  It contains significant developments, forecasts, and important trends, and it quantifies the various market sectors and profiles companies active in those areas. Because of the fragmented nature of the industry, it is difficult to find studies that gather extensive data from such diverse resources and evaluate it in the context of one comprehensive document. This analysis contains a unique collection of membrane device-related information that is difficult or impossible to find elsewhere.
 
INTENDED AUDIENCE
 
This study aims to provide those interested in investment, acquisition, or expansion in the medical membrane device industry with specific, detailed information crucial to making informed decisions. Senior marketing personnel, venture capitalists, executive planners, research directors, and government officials should find the report of value. Readers who simply wish to understand how regulations, market pressures, and technology interact in the medical membrane device arena also will find this study worthwhile.
 
SCOPE OF REPORT
 
Five-year projections for market activity and value are provided. Industry structure, device applications and trends, pricing considerations, R&D, environmental influences, companies, and competitive technologies are included in the study.
To simplify and focus on the most promising and clearly relevant technologies, the study concentrates on existing and potentially major uses of the technology. The membranes used in medical devices work in tandem with other materials and processes, adding critical functionality and value. To clarify the dynamic, the report addresses the membrane component of each sector in context with the market dynamics of the overall technology. The report includes comparison of costs for various membrane materials and devices. Current and potential market players are identified and examined.
 
INFORMATION SOURCES
 
Research for this report began with an in-depth analysis of technical and business literature, as well as a review of the history of the technology. Information from industry experts, company representatives, government researchers, and university scientists provided the basis for an assessment of the outlook for the medical membrane device industry. Secondary sources of information included product literature from membrane and device suppliers, scientific references, and patent searches. 
 
The study is divided into key chapters dealing with the structure and properties of five types of medical membrane devices, including critical components, manufacturing processes necessary for their final function, and their applications. The study emphasizes areas under research and the resulting trends. The report makes projections for each market in terms of constant 2009 dollars. Historical values are presented for the given year, with focus on the U.S. market. Overseas activity is briefly mentioned in order to put the U.S. market into the global context. Estimates of the membrane areas used in particular applications were obtained either from surveys or estimates from knowledgeable industry participants. Final analyses and projections are based upon a combination of a consensus among the primary contacts combined with BCC’s understanding of the impact of trends from a historical perspective.
 
The material presented in this report is based on information gathered from participants in the medical device industry and extensive reviews of secondary sources, such as business, scientific and industry publications, company literature, annual reports, SEC filings, patent literature, and online databases.
 
ANALYSTS CREDENTIALS
 
During the past 7 years, Susan Hanft has authored more than 12 BCC market opportunity reports in the fields of membrane technology, water and wastewater treatment, and bioenergy.
 
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:  
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers
DISCLAIMER
 
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or from its use.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - May-2007| Analyst - Susan Hanft| Code - MST043C

Report Highlights

  • The medical membrane device market, including dialyzers, blood oxygenators, IV filters and blood/apheresis filters, is valued at nearly $1.8 billion in 2007 and is increasing at a compound annual growth rate (CAGR) of 5.3% to reach $ 2.3 billion in 2012.
  • The combined worth of market-driven devices is about $623 million, rising at a compound annual growth rate of 3.6%. More than 235,000 U.S. kidney patients require dialysis on an ongoing basis to maintain renal function. Growth in the hemodialyzer market is driven by an increasing patient population, the phaseout of reusable dialyzers and the discovery that nonmembrane home dialysis may be applicable to a broader target audience
  • Technology driven products, such as blood/apheresis microfilters and diagnostic devices, have a combined value of $1.1 billion, with a 6.2% CAGR. Sales of these products for the most part, are spurred by improvements in design and materials, and by new applications.
Published - Jan-2002| Analyst - Susan Hanft| Code - MST043B

Report Highlights

  • The U.S. medical membrane device market is valued at $1.7 billion in 2001.
  • Increasing at an average annual growth rate (AAGR) of 7.1%, this market is expected to reach nearly $2.5 billion in 2006.
  • Sales of dialyzers and blood oxygenators, and increasingly leukofilters, are primarily market driven and are valued at $883 million in 2001 and growing at an AAGR 8.1%.
  • Sales of IV filters, blood/apheresis filters and diagnostic devices are principally technology driven and have a combined value of $859 million, with a 5.9% AAGR.
  • Sales of diagnostic devices have skyrocketed, driven by managed care, point-of-care and home tests for a host of applications.

CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report